Benicar Lawsuit
- The Fee Is Free Unless You Win®.
- America's Largest Injury Law Firm™
- Protecting Families Since 1988
- 20 Billion+ Won
- 1,000+ Lawyers Nationwide
Announcement
Take our FREE quiz to see if you qualify for a lawsuit.
The attorneys featured above are licensed in Florida. For a full list of attorneys in your state please visit our attorney page.
Benicar Lawsuit
Those who are taking the drug Benicar may experience weight loss, chronic diarrhea, vomiting, and other gastrointestinal (GI) while taking the high blood pressure medication. It has been reported that the drug can cause a GI condition known as sprue-like enteropathy, which causes symptoms similar to those of celiac disease.
Announcement
Take our FREE quiz to see if you qualify for a lawsuit.
How it works
It's easy to get started.
The Fee Is Free™. Only pay if we win.
Results may vary depending on your particular facts and legal circumstances.
Step 1
Submit
your claimWith a free case evaluation, submitting your case is easy with Morgan & Morgan.
Step 2
We take
actionOur dedicated team gets to work investigating your claim.
Step 3
We fight
for youIf we take on the case, our team fights to get you the results you deserve.
Client success
stories that inspire and drive change
Explore over 55,000 5-star reviews and 800 client testimonials to discover why people trust Morgan & Morgan.
Results may vary depending on your particular facts and legal circumstances. Based on Select nationwide reviews
FAQ
Get answers to commonly asked questions about our legal services and learn how we may assist you with your case.
FDA Warns Benicar Use May Cause Enteropathy, GI Side Effects
In July 2013, the FDA announced Benicar (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and in the generic form as olmesartan medoxomil) would receive a product label update to reflect the risk of sprue-like enteropathy.
According to the FDA’s drug safety communication, this GI disorder can cause symptoms that include severe chronic diarrhea with substantial weight loss. The condition may take months or years to develop and may require hospitalization, the agency said.
The link between Benicar and enteropathy was first uncovered in 2012. Researchers from the Mayo Clinic found that over a three-year period, 22 patients taking Benicar displayed symptoms suggestive of celiac disease; however, blood tests for the patients did not support this diagnosis.
When patients stopped taking the drug, their GI symptoms improved, according to one of the authors of the study. Several months later, researchers from the American College of Gastroenterology noted that olmesartan, the active ingredient in Benicar, had been linked to an additional 40 cases of sprue-like enteropathy.
Learn more about how our attorneys can help people in a class action case.